CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 119 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,822,941 | +12.3% | 994,161 | -17.5% | 9.80% | +13.4% |
| Q2 2023 | $13,195,298 | +10.5% | 1,205,050 | -12.0% | 8.65% | -13.2% |
| Q1 2023 | $11,945,763 | +15.2% | 1,369,927 | -17.1% | 9.96% | +11.1% |
| Q4 2022 | $10,367,414 | +27.4% | 1,653,495 | -28.9% | 8.97% | +22.1% |
| Q3 2022 | $8,140,000 | +6.5% | 2,325,833 | -10.2% | 7.34% | +12.8% |
| Q2 2022 | $7,640,000 | +76.9% | 2,589,679 | +86.5% | 6.51% | +62.3% |
| Q1 2022 | $4,318,000 | +4.3% | 1,388,505 | +13.4% | 4.01% | +11.0% |
| Q4 2021 | $4,140,000 | – | 1,224,968 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |